Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity

Hearing Research

Volumn 115, Issue 1-2, 1998, Pages 217-223

  Sone, Michihiko ^a   Schachern, Patricia A ^b   Paparella, Michael M ^b,c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Paparella Ear Head and Neck Institute PA   (United States)

Author keywords

Cystic fibrosis; Degeneration; Ototoxicity; Spiral ganglion cell; Tobramycin

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; NEUROTROPHIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CELL LOSS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYSTIC FIBROSIS; FEMALE; HAIR CELL; HUMAN; HUMAN TISSUE; MALE; NERVE CELL DEGENERATION; OTOTOXICITY; PRIORITY JOURNAL; SPIRAL GANGLION; TEMPORAL BONE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; GENTAMICINS; HAIR CELLS; HEARING LOSS, HIGH-FREQUENCY; HUMANS; NERVE DEGENERATION; SPIRAL GANGLION; TEMPORAL BONE; TOBRAMYCIN;

EID: 0031907842     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(97)00191-3     Document Type: Article

References (46)

1. Aitken M.L., Fiel S.B. Cystic fibrosis. Dis. Mon. 39:1993;1-52.
2. Anniko M., Berggren D., Holm S. Tissue binding kinetics of tobramycin: an experimental study in the mouse inner ear in vitro. Acta Otolaryngol. (Stockh.). 105:1988;120-125.
3. Aran J.M. Current perspectives on inner ear toxicity. Otolaryngol. Head Neck Surg. 112:1995;133-144.
4. Basile A.S., Huang J.M., Xie C., Webster D., Berlin C., Skolnick P. N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nature Med. 2:1996;1338-1343.
5. DeGroot J.C.M.J., Meeuwsen F., Ruizendaal W.E., Veldman J.E. Ultrastructural localization of gentamicin in the cochlea. Hear. Res. 50:1990;35-42.
6. Ehrenberger K., Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey. Acta Otolaryngol. (Stockh.). 115:1995;236-240.
7. Ernfors P., Duan M.L., Elshamy W.M., Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nature Med. 2:1996;463-467.
8. Ernfors P., Canlon B. Aminoglycoside excitement silences hearing. Nature Med. 2:1996;1313-1314.
9. Fausti S.A., Henry J.A., Schaffer H.I., Olson D.J., Frey R.H., McDonald W.J. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J. Infect. Dis. 165:1992;1026-1032.
10. Felder E., Kanonier G., Scholtz A., Rask-Andersen H., Schrott-Fischer A. Quantitative evaluation of cochlear neurons and computer-aided three-dimensional reconstruction of spiral ganglion cells in humans with a peripheral loss of nerve fibres. Hear. Res. 105:1997;183-190.
11. Guild S.R. A graphic reconstruction method for the study of the organ of Corti. Anat. Rec. 22:1921;141-157.
12. Hiel H., Bennani H., Erre J.P., Aurousseau C., Aran J.M. Kinetics of gentamicin in cochlear hair cells after chronic treatment. Acta Otolaryngol. (Stockh.). 112:1992;272-277.
13. Hinojosa R., Lerner S.A. Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. J. Infect. Dis. 156:1987;449-455.
14. Hinojosa R., Riggs L.C., Strauss M., Matz G.J. Temporal bone histopathology of cisplatin ototoxicity. Am. J. Otol. 16:1995;731-740.
15. Huizing E.H., DeGroot J.C.M.J. Human cochlear pathology in aminoglycoside ototoxicity-a review. Acta Otolaryngol. (Stockh.) Suppl. 436:1987;117-125.
16. Huy P.T.B., Bernard P., Schacht J. Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissues and fluids with other organs. J. Clin. Invest. 77:1986;1492-1500.
17. Johnsson L.G., Hawkins J.E. Jr., Kingsley T.C., Black F.O., Matz G.J. Aminoglycoside-induced cochlear pathology in man. Acta Otolaryngol. (Stockh.) Suppl. 383:1981;1-19.
18. Levy J., Smith A.L., Koup J.R., Williams-Warren J., Ramsey B. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. J. Pediatr. 105:1984;117-124.
19. Matz G.J. Aminoglycoside cochlear ototoxicity. Otolaryngol. Clin. North Am. 26:1993;705-712.
20. McCracken G.H. Jr. Aminoglycoside toxicity in infants and children. Am. J. Med. 80:(Suppl. 6B):1986;172-178.
21. Miller, J.J. (1985) CRC Handbook of Ototoxicity. CRC Press, Boca Raton, FL.
22. Moore R.D., Smith C.R., Lietman P.S. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J. Infect. Dis. 149:1984;23-30.
23. Mukhopadhyay S., Baer S., Blanshard J., Coleman M., Carswell F. Assessment of potential ototoxicity following high-dose nebulized tobramycin in patients with cystic fibrosis. J. Antimicrob. Chemother. 31:1993;429-436.
24. Mulherin D., Fahy J., Grant W., Keogan M., Kavanagh B., FitzGerald M. Aminoglycoside induced ototoxicity in patients with cystic fibrosis. Irish J. Med. Sci. 160:1991;173-175.
25. Nadol J.B. Jr. Degeneration of cochlear neurons as seen in the spiral ganglion of man. Hear. Res. 49:1990;141-154.
26. Neu H.C., Benduch C.L. Ototoxicity of tobramycin: a clinical overview. J. Infect. Dis. Suppl. 134:1976;206-218.
27. Niedzielski A.S., Wenthold R.J. Expression of AMPA, kainate, and NMDA receptor subunits in cochlear and vestibular ganglia. J. Neurosci. 15:1995;2338-2853.
28. Nishida I., Takumida M. Attenuation of aminoglycoside ototoxicity by glutathione. J. Otorhinolaryngol. 58:1996;68-73.
29. Otte J., Schuknecht H.F., Kerr A.G. Ganglion cell populations in normal and pathological human cochlea. Implications for cochlear implantation. Laryngoscope. 88:1978;1231-1246.
30. Pauler M., Schuknecht H.F., Thornton A.R. Correlative studies of cochlear neuronal loss with speech discrimination and pure-tone thresholds. Arch. Otorhinolaryngol. 243:1986;200-206.
31. Pirvola U., Cao Y., Oellig C., Suoqiang Z., Pettersson R.F., Ylikoski J. The site of action of neuronal acidic fibroblast growth factor is the organ of Corti of the rat cochlea. Proc. Natl. Acad. Sci. USA. 92:1995;9269-9273.
32. Pullan L.M., Stumpo R.J., Powel R.J., Paschetto K.A., Britt M. Neomycin is an agonist at a polyamine site on the N-methyl-D-aspartate receptor. J. Neurochem. 59:1992;2087-2093.
33. Schacht J. Biochemical basis of aminoglycoside ototoxicity. Otolaryngol. Clin. North Am. 26:1993;845-856.
34. Schuknecht H.F. Techniques for study of cochlear function and pathology in experimental animals: development of the anatomical frequency scale for the cat. Arch. Otolaryngol. 58:1953;377-397.
35. Schuknecht H.F. Auditory and cytocochlear correlates of inner ear disorders. Otolaryngol. Head Neck Surg. 110:1994;530-538.
36. Suzuka Y., Schuknecht H.F. Retrograde cochlear neuronal degeneration in human subjects. Acta Otolaryngol. (Stockh.) Suppl. 450:1988;1-20.
37. Spoendlin H. Factors inducing retrograde degeneration of the cochlear nerve. Ann. Otol. Rhinol. Laryngol. Suppl. 112:1984;76-82.
38. Spoendlin H., Schrott A. The spiral ganglion and the innervation of the human organ of Corti. Acta Otolaryngol. (Stockh.). 105:1988;403-410.
39. Spoendlin H., Schrott A. Analysis of the human auditory nerve. Hear. Res. 43:1989;25-38.
40. Spoendlin H., Schrott A. Quantitative evaluation of the human cochlear nerve. Acta Otolaryngol. (Stockh.) Suppl. 470:1990;61-70.
41. Steinkamp G., Tümmler B., Gappa M., Albus A., Potel J., Döring G., Hardt H.V.D. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr. Pulmonol. 6:1989;91-98.
42. Tange R.A., Conijn E.A.J.G., van Zeiji L.G.P.M., Huizing E.H. Pattern of gentamicin-induced cochlear degeneration in the guinea pig: a morphological and electrophysiological study. Arch. Otorhinolaryngol. 236:1982;173-184.
43. Touw D.J., Vinks A.A.T.M.M., Heijerman H.G.M., Bakker W. Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosis. Ther. Drug Monit. 18:1996;118-123.
44. Wood P.J., Ioannides-Demos L.L., Li S.C., Williams T.J., Hickey B., Spicer W.J., Hooper R.E., McLean A.J. Minimisation of aminoglycoside toxicity in patients with cystic fibrosis. Thorax. 51:1996;369-373.
45. Zheng J.L., Stewart R.R., Gao W.Q. Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J. Neurosci. 15:1995;5079-5087.
46. Zimmermann C.E., Burgess B.J., Nadol J.B. Jr. Patterns of degeneration in the human cochlear nerve. Hear. Res. 90:1995;192-201.